A007570 Stock Overview
Operates as a pharmaceutical company primarily in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for A007570 from our risk checks.
Ilyang Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,260.00 |
| 52 Week High | ₩17,650.00 |
| 52 Week Low | ₩12,300.00 |
| Beta | -0.35 |
| 11 Month Change | 15.69% |
| 3 Month Change | 9.78% |
| 1 Year Change | -12.20% |
| 33 Year Change | -55.31% |
| 5 Year Change | -22.54% |
| Change since IPO | 162.38% |
Recent News & Updates
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Shareholder Returns
| A007570 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 16.4% | 14.1% | 7.9% |
| 1Y | -12.2% | 5.0% | -0.5% |
Return vs Industry: A007570 underperformed the KR Pharmaceuticals industry which returned 2.3% over the past year.
Return vs Market: A007570 underperformed the KR Market which returned -2.4% over the past year.
Price Volatility
| A007570 volatility | |
|---|---|
| A007570 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A007570 has not had significant price volatility in the past 3 months.
Volatility Over Time: A007570's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 535 | Dong-Yeon Kim | www.ilyang.co.kr |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary
| A007570 fundamental statistics | |
|---|---|
| Market cap | ₩274.25b |
| Earnings (TTM) | -₩3.36b |
| Revenue (TTM) | ₩368.71b |
0.7x
P/S Ratio-81.7x
P/E RatioIs A007570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007570 income statement (TTM) | |
|---|---|
| Revenue | ₩368.71b |
| Cost of Revenue | ₩168.51b |
| Gross Profit | ₩200.20b |
| Other Expenses | ₩203.56b |
| Earnings | -₩3.36b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -186.84 |
| Gross Margin | 54.30% |
| Net Profit Margin | -0.91% |
| Debt/Equity Ratio | 34.3% |
How did A007570 perform over the long term?
See historical performance and comparison